Association between leisure time physical activity and markers of chronic inflammation related to coronary heart disease

Atherosclerosis

Volumn 176, Issue 2, 2004, Pages 303-310

  Verdaet, D ^a   Dendale, P ^b   De Bacquer, D ^c   Delanghe, J ^d   Block, P ^a   De Backer, G ^c  

^a FREE UNIVERSITY OF BRUSSELS   (Belgium)

^b VIRGA JESSE HOSPITAL   (Belgium)

^c GHENT UNIVERSITY   (Belgium)

^d GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

C reactive protein; Coronary heart disease; Exercise; Inflammation; Physical activity; Serum amyloid A

Indexed keywords

AMYLOID A PROTEIN; C REACTIVE PROTEIN; FIBRINOGEN;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CORRELATION ANALYSIS; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE MARKER; EDUCATION; ELECTROCARDIOGRAM; FEMALE; HUMAN; INFLAMMATION; ISCHEMIC HEART DISEASE; LEISURE; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUESTIONNAIRE; RISK FACTOR; SMOKING; WORK ENVIRONMENT;

ADULT; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CHRONIC DISEASE; CORONARY ARTERIOSCLEROSIS; CROSS-SECTIONAL STUDIES; EXERCISE; FIBRINOGEN; HUMANS; INFLAMMATION; LIFE STYLE; MALE; MIDDLE AGED; RECREATION; RISK FACTORS; SERUM AMYLOID A PROTEIN;

EID: 5644283437     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2004.05.007     Document Type: Article

References (53)

1. Danesh J., Whincup P., Walker M., et al. Low grade inflammation and coronary artery disease (2003) prospective study and updated meta-analysis. BMJ. 321:2000;199-204
2. Rifai N., Ridker P. High-sensitivity C-reactive protein: a novel and promising marker of coronary artery disease. Clin Chem. 47:2002;403-411
3. Liuzzo G., Biasucci L.M., Gallimore J.R., et al. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. New Engl J Med. 331:1994;417-424
4. Pearson T., Mensah G., et al. Markers of inflammation and cardiovascular disease. Application to clinical and public health practice: a statement for healthcare professionals from the centers for disease control and prevention and the American Heart Association. Circulation. 107:2003;499
5. Yeh E., Willerson J. Coming of age of c-reactive protein: using inflammation parameters in cardiology. Circulation. 107:2003;370
6. Delanghe J., Langlois M., De Bacquer D., et al. Discriminative value of serum amyloid A and other acute-phase proteins for coronary heart disease. Atherosclerosis. 160:2002;471-476
7. Hak E., Stehouwer C., Bots M., et al. Associations of C-reactive protein with measures of obesity, insuline resistance, and subclinical atherosclerosis in healthy, middle-aged women. Arterioscler. Thromb. Vasc. Biol. 19:1999;1986-1991
8. Ridker P., Hennekens C., Buring J., et al. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N. Engl. J. Med. 342:2000;836-843
9. Ridker P. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation. 107:2003;363
10. Libby P., Ridker P.M., Maseri A. Inflammation and atherosclerosis. Circulation. 105:2002;1135
11. Geffken D., Cushman M., Burke G., et al. Association between physical activity and markers of inflammation in a healthy elderly population. Am. J. Epidemiol. 153(3):2001;242-250
12. Onat A., Sansoy V., et al. C-reactive protein and coronary heart disease in Western Turkey. Am. J. Cardiol. 88:2001;601-607
13. Wannamethee G., Lowe G., Whincup P., et al. Physical activity and hemostatic and inflammatory variables in elderly men. Circulation. 105:2002;1785
14. Reuben D., JuddHamilton L., Harris T., et al. The associations between physical activity and inflammatory markers in high-functioning older persons: MacArthur studies of succesfull aging. J. Am. Geriatrics Soc. 51:2003;1125-1130
15. Heilbronn L., Clifton P.M. C-reactive protein and coronary artery disease: influence of obesity. J. Nutritional Biochem. 13:2002;316-321
16. Tchernof A., Nolan A., Sites C., et al. Weight loss reduces C-reactive protein levels in obese postmenopausal women. Circulation. 105:2002;564
17. Lagrand W., Visser C., Hermens W., et al. C-reactive protein as a cardiovascular risk factor: more than a epiphenomenon? Circulation. 100:1999;96-102
18. Gibbons L., Clark M. Exercise in the reduction of cardiovascular events. Exercise in secondary prevention and cardiac rehabilitation. Cardiol. Clin. 19:2001;347-355
19. Leon A., Connet J., Jacobs D.R. Jr., et al. Leisure time physical activity levels and risk of coronary heart disease and death: the multiple risk factor international trial. JAMA. 258:1987;2388-2395
20. Paffenbarger Jr, RS, Hale, W, Work activity and coronary heart mortality, N Engl J Med 1975:545-50.
21. Gielen S., Hambrecht R. Effects of exercise training on vascular function and myocardial perfusion. Exercise in secondary prevention and cardiac rehabilitation. Cardiol Clin. 19:2001;357-368
22. Smith K., Dykes R., Douglas J., et al. Long-term exercise and atherogenic activity of blood mononuclear cells in persons at risk of developing ischemic heart disease. JAMA. 281:1999;1722-1727
23. Taaffe D., Harris T., Ferrucci L., et al. Cross-sectional and prospective relationships of interleukin-6 and C-reactive protein with physical performance in elderly persons MacArthur Studies of Successful Aging. J. Gerontol. Med. Sci. 55A:2000;709-715
24. De Boever E., De Baquer D., Braeckman L., et al. Relation of fibrinogen to lifestyles and to cardiovascular risk factors in a working population. Int. J. Epidemiol. 24:1995;915-921
25. Pitsavos C.h., Chrysohoou C.h., Demosthenes B., et al. Association of leisure time physical activity on inflammation markers (C-reactive protein, white cell blod count, serum amyloid A and fibrinogen) in healthy subjects (from the ATTICA study). Am. J. Cardiol. 91:2003;368-370
26. Rawson E., Freedson P., Osganian S., et al. Body Mass Index, but not physical activity, is associated with C-Reactive Protein. Med. Sci. Sports Exerc. 35:2003;1160-1166
27. Coetsier P., De Backer G., De Corte W., et al. Etude Belge de stress au travail: aperçue de modéles de recherche et des outils d'investigation. Psychol. Psychom. 17:1996;17-35
28. WHO MONICA Project. Geneva, WHO: MONICA Manual; 1990.
29. De Backer G. Nutrition and health: an interuniversity study. Regional differences in dietary habits, coronary risk factors and mortality rates in Belgium. Part I. Design and methodology. Acta Cardiologica. 39:1984;285-292
30. MOSPA, The Monica optional study of physical activity. Jones Deborah, Revised Manual of Operations; 1994.
31. Ledue T.B., Weiner D.L., Sipe J.D., et al. Analytical evaluation of particle-enhanced immunonephelometric assays for C-reactive protein. Ann. Clin. Biochem. 35:1998;745-753
32. N Latex SAA. Instruction leaflet. Dade Behring Marburg Gmbh; 1998.
33. Poole S., Walker D., Gaines Das R.E., et al. The first national standard for serum amyloid A protein (SAA). Evaluation in an international collaborative study. J. Immunol. Meth. 214:1998;1-10
34. Dati F., Schumann G., Thomas L., et al. Consensus of a group of professional societies and diagnostic companies on guidelines for interim reference ranges for 14 proteins in serum based on the standardization against the IFCC/BCR/CAP reference material (CRM 470). Eur. J. Clin. Chem. Clin. Biochem. 34:1996;517-520
35. Rossi E, Mondonico P, Lombardi A, Preda L. Method for the determination of functional (clottable) fibrinogen by the new family of ACL coagulometers, Thromb Res 1988;453-68.
36. Allain C., Poon L., Chan C. Enzymatic determination of total cholesterol. Clin. Chem. 20:1974;470-475
37. Lopez-Virella M., Stone P., Ellis S., Colwell J. Cholesterol determination in high-density lipoproteins separated by three different methods. Clin. Chem. 23:1977;882-884
38. Albert M.A., Danielson E., Rifai N., et al. Effect of statin therapy on C-reactive protein levels: the Pravastatin Inflammation/CRP evaluation (PRINCE) a randomized trial and cohort study. JAMA. 286:2001;64-70
39. Jousilahti P., Salomaa V., Rasi V., et al. The association of C-reactive protein, serum amyloid A and fibrinogen with prevalent coronary heart disease - baseline findings of the Pais Project. Atherosclerosis. 156:2001;451-456
40. Rowe I.F., Soputar A.K., Trayner I.M., et al. Circulating human C-reactive proteins binds very low density lipoproteins. Clin. Exp. Immunol. 58:1984;237-244
41. Der-Min Wu, Nain-Feng Chu, Muh-Han Shen, et al. Plasma C-reactive protein levels and their relationship to anthropometric and lipid characteristics among children. J Clin Epidemiol 56 (2003) 94-100
42. Visser M., Bouter L. McQuillan, et al. Elevated C-reactive protein levels in overweight and obese adults. JAMA. 282:1999;2131-2135
43. Forouhi N.G., Saatar N., McKeigue P.M. Relation of C-reactive protein to body fat distribution and features of the metabolic syndrome in Europeans and South Asians. Int. J. Obes. Relat. Metabol. Disord. 25:2001;1327-1331
44. Manson J.E., Hu F.B., Rich-Edwards J.W., et al. A prospective study of walking as compared with vigorous exercise in the prevention of coronary heart disease in women. New Engl. J. Med. 341:1999;650
45. Siegel A., Stec J., Lipinska I., et al. Effect of marathon running on inflammatory and hemostatic markers. Am. J. Cardiol. 88:2001;918-920
46. Fallon K.A. The acute phase response and exercise: the ultramarathon as prototype exercise. Clin. J. Sports Med. 11:2001;38-43
47. Mattusch F., Dufaux B., Heine O., et al. Reduction of the plasma concentration of C-reactive protein following nine months of endurance training. Int. J. Sports Med. 21(1):2000;21-24
48. LaMonte M, Durstine L, Yanowitz et al. Cardiorespiratory fitness and C-reactive protein among a tri-ethnic sample of woman, Circulation 106 (2002) 40.
49. Church T.S., Barlow C.E., Earnest C.P., et al. Associations between cardiorespiratory fitness and C-reactive protein in men. Atheroscler. Thromb. Vasc. Biol. 22:2002;1869
50. Abrahamson J., Vaccarino V. Relationship between physical activity and inflammation among apparently healthy middle aged and older US adults. Arch. Int. Med. 162:2002;1286-1292
51. Rothenbacher D., Hoffmeister A., Brenner H., et al. Physical activity, coronary heart disease, and inflammatory response. Arch. Int. Med. 136:2003;1200-1205
52. King D.E., Carek P., Mainous A.G., et al. Inflammatory markers and exercise: differences related to exercise type. Med. Sci. Sports Exerc. 35:2003;575-581
53. MacGregor AJ, Gallimore JR, Spector TD, et al. Genetic effects on baseline values of C-reactive protein and serum amyloid A protein: a comparison of monozygotic and dizygotic twins. Clin Chem 21 [Abstract].